ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
4.050
0.00 (0.00%)
At close: Aug 17, 2026
ZIVO Bioscience Market Cap
ZIVO Bioscience has a market cap or net worth of $16.81 million as of August 18, 2026. Its market cap has decreased by -75.86% in one year.
Market Cap
16.81M
Enterprise Value
17.58M
Revenue
209.03K
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.05
ChartMarket Cap Chart
Since October 30, 2003, ZIVO Bioscience's market cap has increased from 2.41M to 16.81M, an increase of 596.72%. That is a compound annual growth rate of 8.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 16.81M | -50.94% |
| Dec 31, 2025 | 34.27M | -55.05% |
| Dec 31, 2024 | 76.25M | 3,046.50% |
| Dec 29, 2023 | 2.42M | -89.71% |
| Dec 30, 2022 | 23.55M | -12.89% |
| Dec 31, 2021 | 27.03M | -56.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 32.91M |
| Provectus Biopharmaceuticals | 23.05M |
| Oncotelic Therapeutics | 18.90M |
| Anebulo Pharmaceuticals | 17.13M |
| EOM Pharmaceuticals Holdings | 16.65M |
| Finch Therapeutics Group | 16.38M |
| Inhibitor Therapeutics | 15.47M |
| Synlogic | 14.04M |